Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Luci vs PreventiveMD

Luci
Graded #101

Lower grade

vs+5.099999999999994
PreventiveMD
Graded #54

Higher grade

The verdict

PreventiveMD takes it — 76.1/100 to 71/100.

PreventiveMD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. PreventiveMD is a physician-guided telehealth platform for GLP-1 weight loss and peptide therapy, offering compounded semaglutide from $83/mo all-in and compounded tirzepatide from $97/mo all-in, plus brand…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
84
84
Dose & formulationPreventiveMD +7
75
82
Clinical oversightPreventiveMD +11
71
82
Labs & monitoringEven
53
53
FulfillmentPreventiveMD +13
70
83
Contract termsEven
55
55
Luci · left barPreventiveMD · right bar

The numbers

MetricLuciPreventiveMD
WeighScore71/10076.1/100
GradeCC
Scorecard rank#101#54
Semaglutide$99/mo (starting dose, promotional rate, compounded)$83/mo (starting dose, compounded)
Tirzepatide$145/mo (starting dose, promotional rate, compounded)$97/mo (starting dose, compounded)
CoverageCoverage not published36 states
Brand-name accessCompounded onlyYes
Oral / sublingualYesInjection only
Luci

Graded #101 · C

Strengths

  • Budget-friendly compounded GLP-1 pricing (compounded semaglutide as low as $99/month, tirzepatide as low as $145/month)
  • Multiple formats: compounded semaglutide and tirzepatide injections plus oral semaglutide and tirzepatide pill kits
  • Upfront pricing with no insurance required and a fast 3-minute questionnaire to start
  • Care delivered through DrTelx, an independent US telehealth medical group, with ongoing support and dose optimization
  • HIPAA-compliant platform with a large self-reported member base (50,000+)

Where it loses points

  • Compounded medications are not FDA-approved for weight loss (the site discloses this) — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • Available only in select U.S. states, and the full state list is not published
  • The compounding pharmacy partner is not named
  • Headline prices are 'as low as' rates (asterisked) — your actual monthly cost may be higher
  • No LegitScript certification displayed; marketing leans heavily on testimonials
PreventiveMD

Graded #54 · C

Strengths

  • Compounded semaglutide from $83/mo and tirzepatide from $97/mo, billed as one all-in monthly price
  • Brand Wegovy, Zepbound, and Foundayo (oral GLP-1) available on the same platform
  • US-licensed provider reviews requests within 24 hours — no video visit required
  • You aren't charged until a provider approves; checkout places an authorization hold only
  • LegitScript-certified; works exclusively with state-licensed US 503A compounding pharmacies

Where it loses points

  • Individual compounding pharmacy partners are not publicly named
  • Not available in 14 states + DC, including New York, New Jersey, Virginia, and Wisconsin
  • Brand Wegovy, Zepbound, and Foundayo require a $49/mo membership fee on top of medication cost
  • 'As low as' pricing — actual monthly cost can be higher depending on your plan
  • Orders become non-refundable once provider review or pharmacy fulfillment begins

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard